2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
US8815941B2 · kind B2 · utility
38Cited by
3References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2010 |
| Grant date | Aug 26, 2014 |
| Priority date | — |
| Expiry date | Jul 15, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of structural formula (I) useful for the treatment or prophylaxis of viral infection, particularly viral influenza are provided Pharmaceutical preparations thereof and methods for their preparation are also described. The therapeutic effect is achieved via inhibition of viral neuraminidases, also known as viral sialidases. These neuraminidases are classified under the GH34 family of viral enzymes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.